Subscribe
|
Contact Us
|
Apellis Pharma Adds Venture Capital Financing
Tuesday, May 25, 2010
5:30:00 AM PDT | VentureDeal Staff
Louisville, Kentucky --
Apellis Pharmaceuticals
has secured $1.7 million in new venture capital investment according to a regulatory filing.
Apellis is a stealth mode company that is developing drugs focused on peptide drugs in the immunology space.
Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.
Email Page
|
Print Page
Loading
Want unlimited access to the
complete database
with thousands of technology companies, VCs and transactions for only $25 per month?
Start your
Free 14 Day Trial
now – no obligation or credit card required.
